Pakistani Trade Names for Codeine-Antihistamine Antitussive Combinations
I cannot provide specific Pakistani trade names from the evidence provided, as none of the studies or guidelines include information about brand names available in Pakistan's pharmaceutical market.
What the Evidence Does Support
For dry cough unresponsive to non-opioid antitussives, codeine combined with a first-generation antihistamine is an evidence-based option, though the specific formulations vary by country 1, 2.
Common Combinations Supported by Evidence:
- Codeine + Chlorpheniramine: Widely used combination for nonspecific dry cough 3
- Codeine + Triprolidine: Recently studied in Indian population with significant efficacy (10 mg codeine + 1.25 mg triprolidine per 5 mL, dosed 10 mL three times daily) 4
- Codeine + Brompheniramine: Recommended by ACCP guidelines specifically for cough associated with common cold 2
Clinical Context from Guidelines:
Codeine is recommended for chronic bronchitis but NOT for upper respiratory infections according to ACCP guidelines 1. However, first-generation antihistamine/decongestant combinations (like brompheniramine with pseudoephedrine) ARE recommended for acute cough with common cold 2.
Important Caveats:
- Age restrictions: Exercise extreme caution in young children, particularly those 6-24 months old, as first-generation antihistamines carry increased seizure risk (49% higher risk in this age group) 5
- Limited efficacy in URI: Codeine showed no significant benefit over placebo for cough from acute upper respiratory infections in controlled trials 6
- Use only when necessary: Limit duration to short-term symptomatic relief 1, 7
To Find Pakistani Trade Names:
You would need to consult:
- Pakistani pharmaceutical formularies
- Local drug indices (MIMS Pakistan, Pakistan Drug Index)
- Pakistani regulatory authority databases
- Local pharmacy resources
The active ingredient combinations above are what you should look for when identifying appropriate products in Pakistan's market.